NCT01496313 2025-10-03To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid CancerSanofiPhase 4 Completed81 enrolled 15 charts
NCT05830500 2023-07-25Study of Anlotinib in Patients With Advanced Medullary Thyroid CarcinomaChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 4 Recruiting360 enrolled